Rodger Novak, President at CRISPR Therapeutics AG (CRSP), sold 25,000 shares at $165.00 ($4.1M) on 2021-06-30, disclosed to the SEC on 2021-07-01.
Open-market sale of $4.1M CRSP by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CRSP | SELL | 2020-12-02 | $6.3M | — | Filing → |
| CRSP | SELL | 2020-10-13 | $2.5M | — | Filing → |
| CRSP | SELL | 2020-09-03 | $4.6M | — | Filing → |